Sequence:

References:

• Saiman L,Tabibi S,Starner TD,San Gabriel P,Winokur PL,Jia HP,McCray PB Jr,Tack BF
  Antimicrob Agents Chemother, 2001, 2838-2844
  
  
  Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.
  
• Kalfa VC,Jia HP,Kunkle RA,McCray PB Jr,Tack BF,Brogden KA
  Antimicrob Agents Chemother, 2001, 3256-3261
  
  
  Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.
  
• Joly S,Maze C,McCray PB Jr,Guthmiller JM
  J Clin Microbiol, 2004, 1024-1029
  
  
  Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.
  
• Travis SM,Anderson NN,Forsyth WR,Espiritu C,Conway BD,Greenberg EP,McCray PB Jr,Lehrer RI,Welsh MJ,Tack BF
  Infect Immun, 2000, 2748-2755
  
  
  Bactericidal activity of mammalian cathelicidin-derived peptides.
  
• Brogden KA,Nordholm G,Ackermann M
  Vet Microbiol, 2007, 76-81
  
  
  Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific.
  
• Jung B,Yun H,Min HJ,Yang S,Shin SY,Lee CW
  Sci Rep, 2023, 1238
  
  
  Discovery of structural and functional transition sites for membrane-penetrating activity of sheep myeloid antimicrobial peptide-18.